C. Wenisch, B. Parschalk, M. Hasenhündl, A. M. Hirschl, W. Graninger: Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. In: Clinical Infectious Diseases. Band 22, Nummer 5, Mai 1996, S. 813–818, PMID 8722937.
Fred A. Zar et al.: A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile–associated diarrhea, stratified by disease severity. In: Clinical Infectious Diseases 45.3, 2007, S. 302–307. PMID 1759930.
Stuart Johnson et al.: Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. In: Clinical Infectious Diseases, 59.3, 2014, S. 345–354. PMID 24799326.
D. Nori, J. M. Cain, B. S. Hilaris, W. B. Jones, J. L. Lewis: Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot study. In: Gynecologic Oncology. Band 16, Nummer 1, August 1983, S. 117–128, PMID 6884824.
J.R.Sarna, S.Furtado, A.K.Brownell: Neurologic complications of metronidazole. In: Can J Neurol Sci. Band 40, Nummer 6, November 2013, S. 768–776, PMID 24257215.
J.Overgaard, H.S.Hansen, M.Overgaard, L.Bastholt, A.Berthelsen, L.Specht et al: A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) In: Radiother Oncol Band 46, Nummer 2, Mai 1998, PMID 9510041.
